Literature DB >> 27935482

Dural sinus stenting for idiopathic intracranial hypertension: factors associated with hemodynamic failure and management with extended stenting.

David A Kumpe1,2, Joshua Seinfeld2, Xianchen Huang1,3, Quelin Mei1,4, David E Case2, Christopher D Roark2, Prem S Subramanian2,5, Kimberly E Lind1, Victoria S Pelak5,6, Jeffrey L Bennett5,6.   

Abstract

BACKGROUND: Some patients undergoing dural sinus stenting for idiopathic intracranial hypertension (IIH) develop clinical and hemodynamic failure (recurrence of the pressure gradient) owing to stent-adjacent stenosis.
OBJECTIVE: To characterize factors associated with hemodynamic failure, and to describe outcomes of patients after repeat stenting.
MATERIALS AND METHODS: We reviewed the initial and follow-up clinical, venographic, and hemodynamic data in 39 patients with IIH treated over 17 years with stenting. Thirty-two had follow-up angiographic and hemodynamic data at 1-99 months (mean 27.6, median 19.5 months). Eight patients were treated with 12 repeat stenting procedures, including extended stenting into the superior sagittal sinus (SSS).
RESULTS: All patients had an initial successful hemodynamic result with the pressure gradient reduced from 10-43 to 0-7 mm Hg. 10/32 patients (31.3%), all women, developed new stenoses in the transverse sinus or posterior SSS above the stent with a recurrent pressure gradient. 7/9 patients with pure extrinsic stenosis of the transverse-sigmoid junction pre-stenting developed new stenoses and hemodynamic failure. All patients with hemodynamic failure who were restented had early and mid-term documented hemodynamic success at 1.7-50 months. They were free from papilledema at 3.8-50 months after the last restenting, and 11.5-99.5 months after initial stent placement (mean 45.3, median 38.5 months).
CONCLUSIONS: Pure extrinsic compression of the transverse-sigmoid junction and female gender were strongly associated with hemodynamic failure. Eight patients with hemodynamic failure who were restented had successful control of papilledema, including 4/4 who had extended stenting into the SSS. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Intervention; Intracranial Pressure; Stenosis; Stent; Vein

Mesh:

Year:  2016        PMID: 27935482     DOI: 10.1136/neurintsurg-2016-012810

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  9 in total

Review 1.  Update on Idiopathic Intracranial Hypertension.

Authors:  Sivashakthi Kanagalingam; Prem S Subramanian
Journal:  Curr Treat Options Neurol       Date:  2018-05-28       Impact factor: 3.598

2.  Long-term Kinetic Papilledema Improvement After Venous Sinus Stenting in Idiopathic Intracranial Hypertension.

Authors:  Romain Touzé; Sophie Bonnin; Emmanuel Houdart; Patrick Nicholson; Bahram Bodaghi; Eimad Shotar; Frédéric Clarençon; Stéphanie Lenck; Valérie Touitou
Journal:  Clin Neuroradiol       Date:  2020-05-12       Impact factor: 3.649

Review 3.  A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH).

Authors:  Aristotelis Kalyvas; Eleftherios Neromyliotis; Christos Koutsarnakis; Spyridon Komaitis; Evangelos Drosos; Georgios P Skandalakis; Mantha Pantazi; Y Pierre Gobin; George Stranjalis; A Patsalides
Journal:  Neurosurg Rev       Date:  2020-04-25       Impact factor: 3.042

Review 4.  Idiopathic Intracranial Hypertension: Contemporary Management and Endovascular Techniques.

Authors:  David Case; Joshua Seinfeld; Christopher Roark; David Kumpe
Journal:  Semin Intervent Radiol       Date:  2020-05-14       Impact factor: 1.513

Review 5.  Stent Survival and Stent-Adjacent Stenosis Rates following Venous Sinus Stenting for Idiopathic Intracranial Hypertension: A Systematic Review and Meta-Analysis.

Authors:  Hamidreza Saber; Whitfield Lewis; Mahsa Sadeghi; Gary Rajah; Sandra Narayanan
Journal:  Interv Neurol       Date:  2018-07-31

6.  Cerebral Venous Wall Diseases: The Other Side of the Picture.

Authors:  S Lenck; P Nicholson
Journal:  AJNR Am J Neuroradiol       Date:  2021-01-07       Impact factor: 3.825

7.  Perioperative mannitol intensive use may avoid the early complication of cerebral venous sinus stenting.

Authors:  Chaobo Bai; Jian Chen; Xiaoqin Wu; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  Ann Transl Med       Date:  2020-06

Review 8.  Exploring The Current Management Idiopathic Intracranial Hypertension, And Understanding The Role Of Dural Venous Sinus Stenting.

Authors:  Sam P Gurney; Sateesh Ramalingam; Alan Thomas; Alex J Sinclair; Susan P Mollan
Journal:  Eye Brain       Date:  2020-01-14

Review 9.  Advances in the Understanding of the Complex Role of Venous Sinus Stenosis in Idiopathic Intracranial Hypertension.

Authors:  Kexin Zhao; Wenjing Gu; Chunmei Liu; Derui Kong; Chong Zheng; Wei Chen; Xuewei Li; Yuchen Liang; Hongwei Zhou
Journal:  J Magn Reson Imaging       Date:  2022-03-31       Impact factor: 5.119

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.